Updates on Ocular Drug Delivery to the Posterior SegmentView Issue
May 2012 | Editor's Page
A Lost Opportunity for Chronic DME
Robert L. Avery, MD, and Allen C. Ho, MD
Vail Vitrectomy: Controversial Elitism or Educational Masterpiece?
Kirk H. Packo, MD, FACS Chair, Vail Vitrectomy Scientific Program and Organizing Committee
The Physician Payments Sunshine Act
Will this legislation impede collaboration between physicians and industry?
With William L. Rich III, MD
May 2012 | Clinical Trials For The Retina Specialist
Recruiting for Invasive Clinical Trials
Aron Shapiro and Ashley Lafond
May 2012 | Fellows' Focus
Financial Advice for Young Physicians
Andre Witkin, MD; Alok S. Bansal, MD; and Nik London, MD
May 2012 | Retina Surgery retina Pearls
Valved Cannula Systems
This technology promotes safe and efficient vitrectomy surgery.
Daniel D. Esmaili, MD
May 2012 | Global Perspectives
Combined Phacoemulsification and Pars Plana Vitrectomy
Combining these procedures benefits both the surgeon and the patient.
Francesco Barca, MD, and Stanislao Rizzo, MD
May 2012 | Surgical Updates
The Advent of Chandelier Illumination in Vitreoretinal Surgery
A panel of surgeons has divergent views on when and how to use these devices.
Rohit Ross Lakhanpal, MD, FACS, and the Vit-Buckle Society
May 2012 | Oncology case Reports In Ocular Oncology
Detection of a Second Primary Tumor During Whole-body Positron Emission Tomography for Choroidal Melanoma
Pradeep Venkatesh, MD; Prakash Agarwal, MD; Rakesh Kumar, MD; and Satpal Garg, MD
May 2012 | Cover Stories
Ocular Drug Delivery Systems for the Posterior Segment: A Review
Noriyuki Kuno, PhD, and Shinobu Fujii
Fluocinolone Implant Will Be Welcome Addition to Therapy Options for DME
UK physician shares impressions from FAME Study.
Andrew J. Lotery, MD, FRCOphth
Sustained Delivery for Retinal Vein Occlusion
For many patients, this method of drug delivery is preferable to rapid attenuation.
Antonio Capone Jr., MD
Drug Delivery Implants for Geographic Atrophy
A number of sustained-delivery technologies are under study.
Baruch D. Kuppermann, MD, PhD
Is Dry AMD Treatable?
A new ophthalmic solution may halt disease progression.
George Chiou, PhD
Are Topical Antibiotics Helpful as Prophylaxis for Intravitreal Injections?
The community standard is evolving toward focusing on antisepsis.
Charles Wykoff, MD, PhD, and Harry W. Flynn Jr., MD
May 2012 | Medical Retina
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery
A clinical study finds the technique effective in treatment of complicated retinal detachments.
P.V. Lyskin, MD, PhD; and Elena G. Kazimirova, MD
May 2012 | New Instrumentation
A New Scleral Depressor
This new instrument is designed to allow for more effective examination of the fundus while being more comfortable and ergonomic for both the physician and patient.
Robert G. Josephberg, MD, and Eduardo Besser, MD